Global Injectable Contraceptives Market is Segmented By Type (Progesterone-only injectables, Combined injectable contraceptives), By Age Group (15-24 years, 25-34 years, 35-44 years, Above 44 years), By Duration of action (Short-acting injectable contraceptives, Long-acting injectable contraceptives), By End User (Hospital, Gynecology clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Injectable Contraceptives Market Overview
Global Injectable Contraceptives Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing with a CAGR of YY % during the forecast period 2023-2030.
The contraceptive injection is a type of contraception (birth control). The injection contains a hormone called depot medroxyprogesterone acetate (DMPA), which is like the hormone progesterone. It is also called simply ‘Depo’ or ‘birth control injection’.The DMPA is slowly released into the bloodstream over 3 months.
DMPA, a substance released slowly into the body, prevents ovaries from releasing eggs and thickens cervix mucus, preventing sperm from entering the uterus. Each injection protects against pregnancy for 12 weeks, and appointments can be made in advance to avoid missed injections. It is essential to have the injection every 12 weeks.
Injectable Contraceptives Market Scope
| Metrics | Details |
| CAGR | YY% |
| Size Available for Years | 2021-2030 |
| Forecast Period | 2023-2030 |
| Data Availability | Value (US$) |
| Segments Covered | Type, Age Group, Duration of action, End-User |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details of the report- Request for sample
Market Dynamics: Drivers and Restraints
Rise in the government initiatives
The rise in government initiatives is one of the significant factors that helps the market to grow during the forecast period.
For instance, in October 2023, The state government of Karnataka launched two new methods of birth control as part of the National Family Planning Programme, The first is a single rod subdermal Expanding the basket of contraceptive choices for couples, the state government on Monday launched two new methods of birth control single rod subdermal implant and subcutaneous injectable contraceptive under the National Family Planning Programme.
Furthermore, in March 2023, the Government of India launched " Mission Parivar Vikas" where the objective is to introduce injectable contraceptive methods at the sub-centre level and expand sterilisation services through the family planning insurance scheme.
Furthermore, the injectables contraceptives market is also driven by various other factors like, a rise in awareness about injectable contraceptives, a rise in awareness about family planning and others will also help the market to grow during the forecast period.
Market Dynamics: Restraint
The aftereffects associated with the use of injectable contraceptives are expected to hamper the growth of the market. Some of the side effects associated with the use of injectable contraceptives are, irregular menstrual bleeding patterns and amenorrhea (the absence of menstrual bleeding). Additionally, other than menstrual disruption, some other side effects were also observed such as weight gain, heavier menstrual bleeding, headaches, dizziness, breast tenderness, body aches, nervousness, fatigue, and acne. Such side effects are somehow making women less interested towards the use of injectable contraceptives, thereby hampering market progress.
Injectable Contraceptives Market Segmentation
The global injectable contraceptive market is segmented based on type, age group, duration of action, end user and region.
The progesterone-only injectables from the type segment accounted for approximately 41.7% of the injectable contraceptives market share
The progesterone-only injectables from the type segment accounted for approximately 41.7% and it is expected to be dominated during the forecast period. Progesterone-only injectables (POIC) is a long-acting, reversible contraceptive. Synthetic progesterone, or progestogen, is slowly released into the systemic circulation following intramuscular (IM) or subcutaneous (SC) injection. Its main mechanism of action is to suppress ovulation. It also makes the endometrium unsuitable for implantation if fertilisation occurs. It also increases the viscosity of cervical mucus, making the mucus less easily penetrable to sperm.
For instance, in August 2022, Aurobindo Pharma Limited wholly owned subsidiary company, of Eugia Pharma Specialties Limited, received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL, 1 mL Single- Dose Vial.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the factors such as the region's well-established healthcare systems facilitating widespread access to a variety of contraceptive options, including injectables and collaborations. Furthermore, the emphasis on reproductive health education and family planning initiatives contributes to a high level of awareness among individuals, enabling them to make informed contraceptive choices.
For instance, in August 2023, Pfizer and Becton, Dickinson & Company (BD) expanded their nearly decade-long collaboration with the Bill and Melinda Gates Foundation, to help enable greater access to injectable contraceptives for millions of women in low- and lower-middle-income countries. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana Press (medroxyprogesterone acetate)l administered by BD Uniject Auto-Disable Prefillable Injection System, through 2030 and is also expected to benefit the whole market.
COVID-19 Impact Analysis
The COVID-19 pandemic had a major impact on the injectable contraceptives market and resulted in a decline in the revenue of the market. The COVID-19 pandemic led to a decline in the number of family planning where injectable contraceptives are utilized. For instance, the United Nations Population Fund (UNFPA) and Avenir Health data, in 2021, reported that approximately 12 million women were unable to receive family planning services with around 1.4 million unplanned pregnancies. Additionally, the pandemic also disrupted the supply chains and manufacturing of injectable contraceptives, which affected the availability of the supplies and resources for family planning.
Competitive Landscape
The major global players in the market include Pfizer Inc., Medcell Pharma, Amphastar Pharmaeceutical Inc, Eugia Pharma, Mylan Labs ltd, PT Tunggal, Gis Medical, Medline, Janani, Facmed Pharmaceuticals and among others.
Key Developments
- In November 2022, Dare Bioscience, Inc., a leader in women’s health innovation, stated a Notice of Award of a grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH) of approximately $249,000 to support end-user research, including surveys of approximately 1,000 women in the U.S. ages 18-44 years, to better understand women’s preferences for a long-acting injectable (LAI) contraceptive method, depression related to opioid stacking on IV Tramadol compared to IV morphine.
Why Purchase the Report?
- To visualize the global injectable contraceptives market segmentation based on type, age group, duration of action, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analysing trends and co-development.
- Excel data sheet with numerous data points of injectable contraceptives market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global injectable contraceptives market report would provide approximately 61 tables, 58 figures and 187 Pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
